News | Heart Failure
Researchers have shown for the first time in preclinical studies that the drug Aliskiren can delay the progression of congestive heart failure and lengthen survival rates. Aliskiren is a drug that inhibits the enzyme that regulates blood pressure.
October 16, 2019
Videos | Hemodynamic Support Devices
Jeffrey J. Popma, M.D., director of interventional cardiology clinical services at Beth Israel Deaconess Medical Center ...
October 16, 2019
Videos | Structural Heart
Vivian Ng, M.D., assistant professor of medicine and an interventional cardiologist at the NewYork-Presbyterian/Columbia ...
October 16, 2019Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
News | Drug-Eluting Balloons
Royal Philips introduced two new balloons to its Stellarex 0.035-inch low-dose drug-coated balloon (DCB) portfolio. The new 200mm and 150mm Stellarex 0.035-inch low-dose DCBs have received approval from the U.S. Food and Drug Administration (FDA) for the treatment of de novo and restenotic lesions in native superficial femoral or popliteal arteries, both arteries in the upper leg. The new balloons broaden physicians’ treatment options for peripheral artery disease (PAD) patients with a high risk of restenosis. The 200mm and 150mm Stellarex 0.035-inch low-dose DCBs are now available in the U.S. and will be rolled out to other markets in due course.
October 15, 2019
News | Cardiac Diagnostics
On-the-job exposure to high levels of pesticides raised the risk of heart disease and stroke in a generally healthy group of Japanese American men in Hawaii, according to new research. The study was published in the Journal of the American Heart Association, the open access journal of the American Heart Association.
October 15, 2019
October 15, 2019 — Kardium Inc. announced that the Globe mapping and ablation system has successfully demonstrated ...
October 15, 2019Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
News | Guidewires
The U.S. Food and Drug Administration (FDA) issued two final guidances for the performance testing and labeling of cardiac catheterization lab devices.
October 11, 2019
Medtronic plc announced the start of a worldwide pivotal study evaluating its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system to treat dangerously fast heart rhythms. The EV ICD system is designed to deliver lifesaving defibrillation and pacing therapy via a device the same size as traditional, transvenous ICDs, but with a lead (thin wire) placed outside the heart and veins.
October 11, 2019
News | Stents Drug Eluting
October 11, 2019 — The ultra-thin Supraflex drug-eluting stent (DES) from SMT maintained numerically lower outcomes at ...
October 11, 2019Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Feature | TCT
The Cardiovascular Research Foundation (CRF) has announced the 12 late-breaking trials and 16 late-breaking science presentations that will be reported at the Transcatheter Cardiovascular Therapeutics (TCT) 2019 scientific symposium. TCT, the world’s premier educational meeting specializing in interventional cardiovascular medicine, will take place Sept. 25 – 29, 2019 at The Moscone Center in San Francisco.
October 11, 2019
Ajay J. Kirtane, M.D., associate professor of medicine at Columbia University Irving Medical Center and director of the cardiac catheterization laboratories at NewYork-Presbyterian (NYP) Hospital, shares the findings of the late-breaking EVOLVE Short DAPT study presented as a late-breaking trial at the 2019 Transcatheter Cardiovascular Therapeutics (TCT) meeting.
October 11, 2019
News | Drug-Eluting Balloons
October 10, 2019 — An independent analysis of Lutonix 035 drug-coated balloon (DCB) patient-level data showed no ...
October 10, 2019Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
News | Hypertension
October 10. 2019 — Late-breaking results from its MODERATO II double-blind, randomized study of BackBeat Cardiac ...
October 10, 2019
Roxana Mehran, M.D., FACC, FACP, FCCP, FESC, FAHA, FSCAI, professor of medicine and director of interventional ...
October 10, 2019
Fujifilm Medical Systems U.S.A. Inc. recently launched Synapse Cardiology PACS 5.6.1, the company’s next-generation server-side rendering solution to help streamline image review and reporting across cardiovascular modalities. This technology is currently in clinical use at North Memorial Health, a Minneapolis-area health system and one of the nation’s top-rated hospitals for cardiovascular care.
October 10, 2019© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now